Keith T. Flaherty - Net Worth and Insider Trading
Keith T. Flaherty Net Worth
The estimated net worth of Keith T. Flaherty is at least $2 Million dollars as of 2024-09-20. Keith T. Flaherty is the Director of Loxo Oncology Inc and owns about 9,732 shares of Loxo Oncology Inc (LOXO) stock worth over $2 Million. Details can be seen in Keith T. Flaherty's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith T. Flaherty has not made any transactions after 2018-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Keith T. Flaherty
Keith T. Flaherty Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith T. Flaherty owns 4 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , Clovis Oncology Inc (CLVSQ) , and Loxo Oncology Inc (LOXO) among others .
Click here to see the complete history of Keith T. Flaherty’s form 4 insider trades.
Insider Ownership Summary of Keith T. Flaherty
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CMPI | Checkmate Pharmaceuticals Inc | 2020-08-06 | director |
| CLVSQ | Clovis Oncology Inc | 2016-06-09 | director |
| LOXO | Loxo Oncology Inc | 2019-02-15 | director |
 | | 2020-12-02 | director |
Keith T. Flaherty Latest Holdings Summary
Keith T. Flaherty currently owns a total of 1 stock. Keith T. Flaherty owns 9,732 shares of Loxo Oncology Inc (LOXO) as of June 7, 2018, with a value of $2 Million.
Latest Holdings of Keith T. Flaherty
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LOXO | Loxo Oncology Inc | 2018-06-07 | 9,732 | 234.66 | 2,283,711 |
Holding Weightings of Keith T. Flaherty
Keith T. Flaherty Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith T. Flaherty has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 50,000 shares on June 7, 2018, which brought Keith T. Flaherty around $9 Million.
Insider Trading History of Keith T. Flaherty
- 1
Keith T. Flaherty Trading Performance
Keith T. Flaherty Ownership Network
Keith T. Flaherty Owned Company Details
What does Checkmate Pharmaceuticals Inc do?
Who are the key executives at Checkmate Pharmaceuticals Inc?
Keith T. Flaherty is the director of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .
Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Checkmate Pharmaceuticals Inc Insider Transactions
Keith T. Flaherty Mailing Address
Above is the net worth, insider trading, and ownership report for Keith T. Flaherty. You might contact Keith T. Flaherty via mailing address: 55 Fruit Street, Yawkey 9e, Boston Ma 02114.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
